location
Global Human Microbiome Sequencing Supply, Demand and Key Producers, 2023-2029

Global Human Microbiome Sequencing Supply, Demand and Key Producers, 2023-2029

Page: 131

Published Date: 26 Feb 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Human Microbiome Sequencing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Human Microbiome Sequencing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Human Microbiome Sequencing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Microbiome Sequencing that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Human Microbiome Sequencing total market, 2018-2029, (USD Million)
Global Human Microbiome Sequencing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Human Microbiome Sequencing total market, key domestic companies and share, (USD Million)
Global Human Microbiome Sequencing revenue by player and market share 2018-2023, (USD Million)
Global Human Microbiome Sequencing total market by Type, CAGR, 2018-2029, (USD Million)
Global Human Microbiome Sequencing total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Human Microbiome Sequencing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baseclear B.V., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Charles River Laboratories International Inc., Clinical Microbiomics A/S, Eurofins Scientific SE, GENEWIZ, Inc., Illumina, Inc., Novogene Corporation and OraSure Technologies, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Microbiome Sequencing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Human Microbiome Sequencing Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Human Microbiome Sequencing Market, Segmentation by Type
    Next-Generation Sequencing
    Traditional Sequencing Technologies
    Other

Global Human Microbiome Sequencing Market, Segmentation by Application
    Genome Analysis
    Metabolome Analysis
    Transcriptome Analysis
    Other Omics Analysis

Companies Profiled:
    Baseclear B.V.
    Beijing Genomics Institute (BGI) Genomics Co., Ltd
    Charles River Laboratories International Inc.
    Clinical Microbiomics A/S
    Eurofins Scientific SE
    GENEWIZ, Inc.
    Illumina, Inc.
    Novogene Corporation
    OraSure Technologies, Inc.
    Oxford Nanopore Technologies, Inc.
    Pacific Biosciences of California, Inc.
    QIAGEN N.V.
    Second Genome, Inc.
    Thermo Fisher Scientific Inc.
    Viome, Inc.
    CosmosID
    Leucine Rich Bio Pvt. Ltd.
    Microba
    Microbiome Insights Inc.
    Molzym GmbH & Co. KG

Key Questions Answered
1. How big is the global Human Microbiome Sequencing market?
2. What is the demand of the global Human Microbiome Sequencing market?
3. What is the year over year growth of the global Human Microbiome Sequencing market?
4. What is the total value of the global Human Microbiome Sequencing market?
5. Who are the major players in the global Human Microbiome Sequencing market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
    1.1 Human Microbiome Sequencing Introduction
    1.2 World Human Microbiome Sequencing Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Human Microbiome Sequencing Total Market by Region (by Headquarter Location)
        1.3.1 World Human Microbiome Sequencing Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Human Microbiome Sequencing Market Size (2018-2029)
        1.3.3 China Human Microbiome Sequencing Market Size (2018-2029)
        1.3.4 Europe Human Microbiome Sequencing Market Size (2018-2029)
        1.3.5 Japan Human Microbiome Sequencing Market Size (2018-2029)
        1.3.6 South Korea Human Microbiome Sequencing Market Size (2018-2029)
        1.3.7 ASEAN Human Microbiome Sequencing Market Size (2018-2029)
        1.3.8 India Human Microbiome Sequencing Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Human Microbiome Sequencing Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Human Microbiome Sequencing Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Human Microbiome Sequencing Consumption Value (2018-2029)
    2.2 World Human Microbiome Sequencing Consumption Value by Region
        2.2.1 World Human Microbiome Sequencing Consumption Value by Region (2018-2023)
        2.2.2 World Human Microbiome Sequencing Consumption Value Forecast by Region (2024-2029)
    2.3 United States Human Microbiome Sequencing Consumption Value (2018-2029)
    2.4 China Human Microbiome Sequencing Consumption Value (2018-2029)
    2.5 Europe Human Microbiome Sequencing Consumption Value (2018-2029)
    2.6 Japan Human Microbiome Sequencing Consumption Value (2018-2029)
    2.7 South Korea Human Microbiome Sequencing Consumption Value (2018-2029)
    2.8 ASEAN Human Microbiome Sequencing Consumption Value (2018-2029)
    2.9 India Human Microbiome Sequencing Consumption Value (2018-2029)

3 World Human Microbiome Sequencing Companies Competitive Analysis
    3.1 World Human Microbiome Sequencing Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Human Microbiome Sequencing Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Human Microbiome Sequencing in 2022
        3.2.3 Global Concentration Ratios (CR8) for Human Microbiome Sequencing in 2022
    3.3 Human Microbiome Sequencing Company Evaluation Quadrant
    3.4 Human Microbiome Sequencing Market: Overall Company Footprint Analysis
        3.4.1 Human Microbiome Sequencing Market: Region Footprint
        3.4.2 Human Microbiome Sequencing Market: Company Product Type Footprint
        3.4.3 Human Microbiome Sequencing Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Human Microbiome Sequencing Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Human Microbiome Sequencing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Human Microbiome Sequencing Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Human Microbiome Sequencing Consumption Value Comparison
        4.2.1 United States VS China: Human Microbiome Sequencing Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Human Microbiome Sequencing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Human Microbiome Sequencing Companies and Market Share, 2018-2023
        4.3.1 United States Based Human Microbiome Sequencing Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Human Microbiome Sequencing Revenue, (2018-2023)
    4.4 China Based Companies Human Microbiome Sequencing Revenue and Market Share, 2018-2023
        4.4.1 China Based Human Microbiome Sequencing Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Human Microbiome Sequencing Revenue, (2018-2023)
    4.5 Rest of World Based Human Microbiome Sequencing Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Human Microbiome Sequencing Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Human Microbiome Sequencing Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Human Microbiome Sequencing Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Next-Generation Sequencing
        5.2.2 Traditional Sequencing Technologies
        5.2.3 Other
    5.3 Market Segment by Type
        5.3.1 World Human Microbiome Sequencing Market Size by Type (2018-2023)
        5.3.2 World Human Microbiome Sequencing Market Size by Type (2024-2029)
        5.3.3 World Human Microbiome Sequencing Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Human Microbiome Sequencing Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Genome Analysis
        6.2.2 Metabolome Analysis
        6.2.3 Transcriptome Analysis
        6.2.4 Other Omics Analysis
        6.2.5 Other Omics Analysis
    6.3 Market Segment by Application
        6.3.1 World Human Microbiome Sequencing Market Size by Application (2018-2023)
        6.3.2 World Human Microbiome Sequencing Market Size by Application (2024-2029)
        6.3.3 World Human Microbiome Sequencing Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Baseclear B.V.
        7.1.1 Baseclear B.V. Details
        7.1.2 Baseclear B.V. Major Business
        7.1.3 Baseclear B.V. Human Microbiome Sequencing Product and Services
        7.1.4 Baseclear B.V. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Baseclear B.V. Recent Developments/Updates
        7.1.6 Baseclear B.V. Competitive Strengths & Weaknesses
    7.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd
        7.2.1 Beijing Genomics Institute (BGI) Genomics Co., Ltd Details
        7.2.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd Major Business
        7.2.3 Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Product and Services
        7.2.4 Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Beijing Genomics Institute (BGI) Genomics Co., Ltd Recent Developments/Updates
        7.2.6 Beijing Genomics Institute (BGI) Genomics Co., Ltd Competitive Strengths & Weaknesses
    7.3 Charles River Laboratories International Inc.
        7.3.1 Charles River Laboratories International Inc. Details
        7.3.2 Charles River Laboratories International Inc. Major Business
        7.3.3 Charles River Laboratories International Inc. Human Microbiome Sequencing Product and Services
        7.3.4 Charles River Laboratories International Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Charles River Laboratories International Inc. Recent Developments/Updates
        7.3.6 Charles River Laboratories International Inc. Competitive Strengths & Weaknesses
    7.4 Clinical Microbiomics A/S
        7.4.1 Clinical Microbiomics A/S Details
        7.4.2 Clinical Microbiomics A/S Major Business
        7.4.3 Clinical Microbiomics A/S Human Microbiome Sequencing Product and Services
        7.4.4 Clinical Microbiomics A/S Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Clinical Microbiomics A/S Recent Developments/Updates
        7.4.6 Clinical Microbiomics A/S Competitive Strengths & Weaknesses
    7.5 Eurofins Scientific SE
        7.5.1 Eurofins Scientific SE Details
        7.5.2 Eurofins Scientific SE Major Business
        7.5.3 Eurofins Scientific SE Human Microbiome Sequencing Product and Services
        7.5.4 Eurofins Scientific SE Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Eurofins Scientific SE Recent Developments/Updates
        7.5.6 Eurofins Scientific SE Competitive Strengths & Weaknesses
    7.6 GENEWIZ, Inc.
        7.6.1 GENEWIZ, Inc. Details
        7.6.2 GENEWIZ, Inc. Major Business
        7.6.3 GENEWIZ, Inc. Human Microbiome Sequencing Product and Services
        7.6.4 GENEWIZ, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 GENEWIZ, Inc. Recent Developments/Updates
        7.6.6 GENEWIZ, Inc. Competitive Strengths & Weaknesses
    7.7 Illumina, Inc.
        7.7.1 Illumina, Inc. Details
        7.7.2 Illumina, Inc. Major Business
        7.7.3 Illumina, Inc. Human Microbiome Sequencing Product and Services
        7.7.4 Illumina, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Illumina, Inc. Recent Developments/Updates
        7.7.6 Illumina, Inc. Competitive Strengths & Weaknesses
    7.8 Novogene Corporation
        7.8.1 Novogene Corporation Details
        7.8.2 Novogene Corporation Major Business
        7.8.3 Novogene Corporation Human Microbiome Sequencing Product and Services
        7.8.4 Novogene Corporation Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Novogene Corporation Recent Developments/Updates
        7.8.6 Novogene Corporation Competitive Strengths & Weaknesses
    7.9 OraSure Technologies, Inc.
        7.9.1 OraSure Technologies, Inc. Details
        7.9.2 OraSure Technologies, Inc. Major Business
        7.9.3 OraSure Technologies, Inc. Human Microbiome Sequencing Product and Services
        7.9.4 OraSure Technologies, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 OraSure Technologies, Inc. Recent Developments/Updates
        7.9.6 OraSure Technologies, Inc. Competitive Strengths & Weaknesses
    7.10 Oxford Nanopore Technologies, Inc.
        7.10.1 Oxford Nanopore Technologies, Inc. Details
        7.10.2 Oxford Nanopore Technologies, Inc. Major Business
        7.10.3 Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Product and Services
        7.10.4 Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Oxford Nanopore Technologies, Inc. Recent Developments/Updates
        7.10.6 Oxford Nanopore Technologies, Inc. Competitive Strengths & Weaknesses
    7.11 Pacific Biosciences of California, Inc.
        7.11.1 Pacific Biosciences of California, Inc. Details
        7.11.2 Pacific Biosciences of California, Inc. Major Business
        7.11.3 Pacific Biosciences of California, Inc. Human Microbiome Sequencing Product and Services
        7.11.4 Pacific Biosciences of California, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Pacific Biosciences of California, Inc. Recent Developments/Updates
        7.11.6 Pacific Biosciences of California, Inc. Competitive Strengths & Weaknesses
    7.12 QIAGEN N.V.
        7.12.1 QIAGEN N.V. Details
        7.12.2 QIAGEN N.V. Major Business
        7.12.3 QIAGEN N.V. Human Microbiome Sequencing Product and Services
        7.12.4 QIAGEN N.V. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 QIAGEN N.V. Recent Developments/Updates
        7.12.6 QIAGEN N.V. Competitive Strengths & Weaknesses
    7.13 Second Genome, Inc.
        7.13.1 Second Genome, Inc. Details
        7.13.2 Second Genome, Inc. Major Business
        7.13.3 Second Genome, Inc. Human Microbiome Sequencing Product and Services
        7.13.4 Second Genome, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Second Genome, Inc. Recent Developments/Updates
        7.13.6 Second Genome, Inc. Competitive Strengths & Weaknesses
    7.14 Thermo Fisher Scientific Inc.
        7.14.1 Thermo Fisher Scientific Inc. Details
        7.14.2 Thermo Fisher Scientific Inc. Major Business
        7.14.3 Thermo Fisher Scientific Inc. Human Microbiome Sequencing Product and Services
        7.14.4 Thermo Fisher Scientific Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
        7.14.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
    7.15 Viome, Inc.
        7.15.1 Viome, Inc. Details
        7.15.2 Viome, Inc. Major Business
        7.15.3 Viome, Inc. Human Microbiome Sequencing Product and Services
        7.15.4 Viome, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Viome, Inc. Recent Developments/Updates
        7.15.6 Viome, Inc. Competitive Strengths & Weaknesses
    7.16 CosmosID
        7.16.1 CosmosID Details
        7.16.2 CosmosID Major Business
        7.16.3 CosmosID Human Microbiome Sequencing Product and Services
        7.16.4 CosmosID Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 CosmosID Recent Developments/Updates
        7.16.6 CosmosID Competitive Strengths & Weaknesses
    7.17 Leucine Rich Bio Pvt. Ltd.
        7.17.1 Leucine Rich Bio Pvt. Ltd. Details
        7.17.2 Leucine Rich Bio Pvt. Ltd. Major Business
        7.17.3 Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Product and Services
        7.17.4 Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.17.5 Leucine Rich Bio Pvt. Ltd. Recent Developments/Updates
        7.17.6 Leucine Rich Bio Pvt. Ltd. Competitive Strengths & Weaknesses
    7.18 Microba
        7.18.1 Microba Details
        7.18.2 Microba Major Business
        7.18.3 Microba Human Microbiome Sequencing Product and Services
        7.18.4 Microba Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.18.5 Microba Recent Developments/Updates
        7.18.6 Microba Competitive Strengths & Weaknesses
    7.19 Microbiome Insights Inc.
        7.19.1 Microbiome Insights Inc. Details
        7.19.2 Microbiome Insights Inc. Major Business
        7.19.3 Microbiome Insights Inc. Human Microbiome Sequencing Product and Services
        7.19.4 Microbiome Insights Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.19.5 Microbiome Insights Inc. Recent Developments/Updates
        7.19.6 Microbiome Insights Inc. Competitive Strengths & Weaknesses
    7.20 Molzym GmbH & Co. KG
        7.20.1 Molzym GmbH & Co. KG Details
        7.20.2 Molzym GmbH & Co. KG Major Business
        7.20.3 Molzym GmbH & Co. KG Human Microbiome Sequencing Product and Services
        7.20.4 Molzym GmbH & Co. KG Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.20.5 Molzym GmbH & Co. KG Recent Developments/Updates
        7.20.6 Molzym GmbH & Co. KG Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Human Microbiome Sequencing Industry Chain
    8.2 Human Microbiome Sequencing Upstream Analysis
    8.3 Human Microbiome Sequencing Midstream Analysis
    8.4 Human Microbiome Sequencing Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer
btl

Table of Figures

List of Tables
    Table 1. World Human Microbiome Sequencing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Human Microbiome Sequencing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Human Microbiome Sequencing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Human Microbiome Sequencing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Human Microbiome Sequencing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Human Microbiome Sequencing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Human Microbiome Sequencing Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Human Microbiome Sequencing Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Human Microbiome Sequencing Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Human Microbiome Sequencing Players in 2022
    Table 12. World Human Microbiome Sequencing Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Human Microbiome Sequencing Company Evaluation Quadrant
    Table 14. Head Office of Key Human Microbiome Sequencing Player
    Table 15. Human Microbiome Sequencing Market: Company Product Type Footprint
    Table 16. Human Microbiome Sequencing Market: Company Product Application Footprint
    Table 17. Human Microbiome Sequencing Mergers & Acquisitions Activity
    Table 18. United States VS China Human Microbiome Sequencing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Human Microbiome Sequencing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Human Microbiome Sequencing Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Human Microbiome Sequencing Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Human Microbiome Sequencing Revenue Market Share (2018-2023)
    Table 23. China Based Human Microbiome Sequencing Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Human Microbiome Sequencing Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Human Microbiome Sequencing Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Human Microbiome Sequencing Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Human Microbiome Sequencing Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Human Microbiome Sequencing Revenue Market Share (2018-2023)
    Table 29. World Human Microbiome Sequencing Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Human Microbiome Sequencing Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Human Microbiome Sequencing Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Human Microbiome Sequencing Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Human Microbiome Sequencing Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Human Microbiome Sequencing Market Size by Application (2024-2029) & (USD Million)
    Table 35. Baseclear B.V. Basic Information, Area Served and Competitors
    Table 36. Baseclear B.V. Major Business
    Table 37. Baseclear B.V. Human Microbiome Sequencing Product and Services
    Table 38. Baseclear B.V. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Baseclear B.V. Recent Developments/Updates
    Table 40. Baseclear B.V. Competitive Strengths & Weaknesses
    Table 41. Beijing Genomics Institute (BGI) Genomics Co., Ltd Basic Information, Area Served and Competitors
    Table 42. Beijing Genomics Institute (BGI) Genomics Co., Ltd Major Business
    Table 43. Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Product and Services
    Table 44. Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Beijing Genomics Institute (BGI) Genomics Co., Ltd Recent Developments/Updates
    Table 46. Beijing Genomics Institute (BGI) Genomics Co., Ltd Competitive Strengths & Weaknesses
    Table 47. Charles River Laboratories International Inc. Basic Information, Area Served and Competitors
    Table 48. Charles River Laboratories International Inc. Major Business
    Table 49. Charles River Laboratories International Inc. Human Microbiome Sequencing Product and Services
    Table 50. Charles River Laboratories International Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Charles River Laboratories International Inc. Recent Developments/Updates
    Table 52. Charles River Laboratories International Inc. Competitive Strengths & Weaknesses
    Table 53. Clinical Microbiomics A/S Basic Information, Area Served and Competitors
    Table 54. Clinical Microbiomics A/S Major Business
    Table 55. Clinical Microbiomics A/S Human Microbiome Sequencing Product and Services
    Table 56. Clinical Microbiomics A/S Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Clinical Microbiomics A/S Recent Developments/Updates
    Table 58. Clinical Microbiomics A/S Competitive Strengths & Weaknesses
    Table 59. Eurofins Scientific SE Basic Information, Area Served and Competitors
    Table 60. Eurofins Scientific SE Major Business
    Table 61. Eurofins Scientific SE Human Microbiome Sequencing Product and Services
    Table 62. Eurofins Scientific SE Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Eurofins Scientific SE Recent Developments/Updates
    Table 64. Eurofins Scientific SE Competitive Strengths & Weaknesses
    Table 65. GENEWIZ, Inc. Basic Information, Area Served and Competitors
    Table 66. GENEWIZ, Inc. Major Business
    Table 67. GENEWIZ, Inc. Human Microbiome Sequencing Product and Services
    Table 68. GENEWIZ, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. GENEWIZ, Inc. Recent Developments/Updates
    Table 70. GENEWIZ, Inc. Competitive Strengths & Weaknesses
    Table 71. Illumina, Inc. Basic Information, Area Served and Competitors
    Table 72. Illumina, Inc. Major Business
    Table 73. Illumina, Inc. Human Microbiome Sequencing Product and Services
    Table 74. Illumina, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Illumina, Inc. Recent Developments/Updates
    Table 76. Illumina, Inc. Competitive Strengths & Weaknesses
    Table 77. Novogene Corporation Basic Information, Area Served and Competitors
    Table 78. Novogene Corporation Major Business
    Table 79. Novogene Corporation Human Microbiome Sequencing Product and Services
    Table 80. Novogene Corporation Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Novogene Corporation Recent Developments/Updates
    Table 82. Novogene Corporation Competitive Strengths & Weaknesses
    Table 83. OraSure Technologies, Inc. Basic Information, Area Served and Competitors
    Table 84. OraSure Technologies, Inc. Major Business
    Table 85. OraSure Technologies, Inc. Human Microbiome Sequencing Product and Services
    Table 86. OraSure Technologies, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. OraSure Technologies, Inc. Recent Developments/Updates
    Table 88. OraSure Technologies, Inc. Competitive Strengths & Weaknesses
    Table 89. Oxford Nanopore Technologies, Inc. Basic Information, Area Served and Competitors
    Table 90. Oxford Nanopore Technologies, Inc. Major Business
    Table 91. Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Product and Services
    Table 92. Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Oxford Nanopore Technologies, Inc. Recent Developments/Updates
    Table 94. Oxford Nanopore Technologies, Inc. Competitive Strengths & Weaknesses
    Table 95. Pacific Biosciences of California, Inc. Basic Information, Area Served and Competitors
    Table 96. Pacific Biosciences of California, Inc. Major Business
    Table 97. Pacific Biosciences of California, Inc. Human Microbiome Sequencing Product and Services
    Table 98. Pacific Biosciences of California, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Pacific Biosciences of California, Inc. Recent Developments/Updates
    Table 100. Pacific Biosciences of California, Inc. Competitive Strengths & Weaknesses
    Table 101. QIAGEN N.V. Basic Information, Area Served and Competitors
    Table 102. QIAGEN N.V. Major Business
    Table 103. QIAGEN N.V. Human Microbiome Sequencing Product and Services
    Table 104. QIAGEN N.V. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. QIAGEN N.V. Recent Developments/Updates
    Table 106. QIAGEN N.V. Competitive Strengths & Weaknesses
    Table 107. Second Genome, Inc. Basic Information, Area Served and Competitors
    Table 108. Second Genome, Inc. Major Business
    Table 109. Second Genome, Inc. Human Microbiome Sequencing Product and Services
    Table 110. Second Genome, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Second Genome, Inc. Recent Developments/Updates
    Table 112. Second Genome, Inc. Competitive Strengths & Weaknesses
    Table 113. Thermo Fisher Scientific Inc. Basic Information, Area Served and Competitors
    Table 114. Thermo Fisher Scientific Inc. Major Business
    Table 115. Thermo Fisher Scientific Inc. Human Microbiome Sequencing Product and Services
    Table 116. Thermo Fisher Scientific Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Thermo Fisher Scientific Inc. Recent Developments/Updates
    Table 118. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
    Table 119. Viome, Inc. Basic Information, Area Served and Competitors
    Table 120. Viome, Inc. Major Business
    Table 121. Viome, Inc. Human Microbiome Sequencing Product and Services
    Table 122. Viome, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Viome, Inc. Recent Developments/Updates
    Table 124. Viome, Inc. Competitive Strengths & Weaknesses
    Table 125. CosmosID Basic Information, Area Served and Competitors
    Table 126. CosmosID Major Business
    Table 127. CosmosID Human Microbiome Sequencing Product and Services
    Table 128. CosmosID Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 129. CosmosID Recent Developments/Updates
    Table 130. CosmosID Competitive Strengths & Weaknesses
    Table 131. Leucine Rich Bio Pvt. Ltd. Basic Information, Area Served and Competitors
    Table 132. Leucine Rich Bio Pvt. Ltd. Major Business
    Table 133. Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Product and Services
    Table 134. Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 135. Leucine Rich Bio Pvt. Ltd. Recent Developments/Updates
    Table 136. Leucine Rich Bio Pvt. Ltd. Competitive Strengths & Weaknesses
    Table 137. Microba Basic Information, Area Served and Competitors
    Table 138. Microba Major Business
    Table 139. Microba Human Microbiome Sequencing Product and Services
    Table 140. Microba Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 141. Microba Recent Developments/Updates
    Table 142. Microba Competitive Strengths & Weaknesses
    Table 143. Microbiome Insights Inc. Basic Information, Area Served and Competitors
    Table 144. Microbiome Insights Inc. Major Business
    Table 145. Microbiome Insights Inc. Human Microbiome Sequencing Product and Services
    Table 146. Microbiome Insights Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 147. Microbiome Insights Inc. Recent Developments/Updates
    Table 148. Molzym GmbH & Co. KG Basic Information, Area Served and Competitors
    Table 149. Molzym GmbH & Co. KG Major Business
    Table 150. Molzym GmbH & Co. KG Human Microbiome Sequencing Product and Services
    Table 151. Molzym GmbH & Co. KG Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 152. Global Key Players of Human Microbiome Sequencing Upstream (Raw Materials)
    Table 153. Human Microbiome Sequencing Typical Customers
List of Figure
    Figure 1. Human Microbiome Sequencing Picture
    Figure 2. World Human Microbiome Sequencing Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Human Microbiome Sequencing Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Human Microbiome Sequencing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Human Microbiome Sequencing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Human Microbiome Sequencing Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Human Microbiome Sequencing Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Human Microbiome Sequencing Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Human Microbiome Sequencing Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Human Microbiome Sequencing Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Human Microbiome Sequencing Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Human Microbiome Sequencing Revenue (2018-2029) & (USD Million)
    Figure 13. Human Microbiome Sequencing Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Human Microbiome Sequencing Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Human Microbiome Sequencing Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Human Microbiome Sequencing Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Human Microbiome Sequencing Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Human Microbiome Sequencing Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Human Microbiome Sequencing Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Human Microbiome Sequencing Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Human Microbiome Sequencing Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Human Microbiome Sequencing Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Human Microbiome Sequencing by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Human Microbiome Sequencing Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Human Microbiome Sequencing Markets in 2022
    Figure 27. United States VS China: Human Microbiome Sequencing Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Human Microbiome Sequencing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Human Microbiome Sequencing Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Human Microbiome Sequencing Market Size Market Share by Type in 2022
    Figure 31. Next-Generation Sequencing
    Figure 32. Traditional Sequencing Technologies
    Figure 33. Other
    Figure 34. World Human Microbiome Sequencing Market Size Market Share by Type (2018-2029)
    Figure 35. World Human Microbiome Sequencing Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Human Microbiome Sequencing Market Size Market Share by Application in 2022
    Figure 37. Genome Analysis
    Figure 38. Metabolome Analysis
    Figure 39. Transcriptome Analysis
    Figure 40. Other Omics Analysis
    Figure 41. Human Microbiome Sequencing Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Related Reports

btl

Product Tags

Human Microbiome Sequencing

Human Microbiome Sequencing Technology

Human Microbiome Sequencing Instrument

Human Microbiome Sequencing Services

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Human Microbiome Sequencing Supply, Demand and Key Producers, 2023-2029

Global Human Microbiome Sequencing Supply, Demand and Key Producers, 2023-2029

Page: 131

Published Date: 26 Feb 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Human Microbiome Sequencing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Human Microbiome Sequencing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Human Microbiome Sequencing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Microbiome Sequencing that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Human Microbiome Sequencing total market, 2018-2029, (USD Million)
Global Human Microbiome Sequencing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Human Microbiome Sequencing total market, key domestic companies and share, (USD Million)
Global Human Microbiome Sequencing revenue by player and market share 2018-2023, (USD Million)
Global Human Microbiome Sequencing total market by Type, CAGR, 2018-2029, (USD Million)
Global Human Microbiome Sequencing total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Human Microbiome Sequencing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baseclear B.V., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Charles River Laboratories International Inc., Clinical Microbiomics A/S, Eurofins Scientific SE, GENEWIZ, Inc., Illumina, Inc., Novogene Corporation and OraSure Technologies, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Microbiome Sequencing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Human Microbiome Sequencing Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Human Microbiome Sequencing Market, Segmentation by Type
    Next-Generation Sequencing
    Traditional Sequencing Technologies
    Other

Global Human Microbiome Sequencing Market, Segmentation by Application
    Genome Analysis
    Metabolome Analysis
    Transcriptome Analysis
    Other Omics Analysis

Companies Profiled:
    Baseclear B.V.
    Beijing Genomics Institute (BGI) Genomics Co., Ltd
    Charles River Laboratories International Inc.
    Clinical Microbiomics A/S
    Eurofins Scientific SE
    GENEWIZ, Inc.
    Illumina, Inc.
    Novogene Corporation
    OraSure Technologies, Inc.
    Oxford Nanopore Technologies, Inc.
    Pacific Biosciences of California, Inc.
    QIAGEN N.V.
    Second Genome, Inc.
    Thermo Fisher Scientific Inc.
    Viome, Inc.
    CosmosID
    Leucine Rich Bio Pvt. Ltd.
    Microba
    Microbiome Insights Inc.
    Molzym GmbH & Co. KG

Key Questions Answered
1. How big is the global Human Microbiome Sequencing market?
2. What is the demand of the global Human Microbiome Sequencing market?
3. What is the year over year growth of the global Human Microbiome Sequencing market?
4. What is the total value of the global Human Microbiome Sequencing market?
5. Who are the major players in the global Human Microbiome Sequencing market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
    1.1 Human Microbiome Sequencing Introduction
    1.2 World Human Microbiome Sequencing Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Human Microbiome Sequencing Total Market by Region (by Headquarter Location)
        1.3.1 World Human Microbiome Sequencing Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Human Microbiome Sequencing Market Size (2018-2029)
        1.3.3 China Human Microbiome Sequencing Market Size (2018-2029)
        1.3.4 Europe Human Microbiome Sequencing Market Size (2018-2029)
        1.3.5 Japan Human Microbiome Sequencing Market Size (2018-2029)
        1.3.6 South Korea Human Microbiome Sequencing Market Size (2018-2029)
        1.3.7 ASEAN Human Microbiome Sequencing Market Size (2018-2029)
        1.3.8 India Human Microbiome Sequencing Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Human Microbiome Sequencing Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Human Microbiome Sequencing Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Human Microbiome Sequencing Consumption Value (2018-2029)
    2.2 World Human Microbiome Sequencing Consumption Value by Region
        2.2.1 World Human Microbiome Sequencing Consumption Value by Region (2018-2023)
        2.2.2 World Human Microbiome Sequencing Consumption Value Forecast by Region (2024-2029)
    2.3 United States Human Microbiome Sequencing Consumption Value (2018-2029)
    2.4 China Human Microbiome Sequencing Consumption Value (2018-2029)
    2.5 Europe Human Microbiome Sequencing Consumption Value (2018-2029)
    2.6 Japan Human Microbiome Sequencing Consumption Value (2018-2029)
    2.7 South Korea Human Microbiome Sequencing Consumption Value (2018-2029)
    2.8 ASEAN Human Microbiome Sequencing Consumption Value (2018-2029)
    2.9 India Human Microbiome Sequencing Consumption Value (2018-2029)

3 World Human Microbiome Sequencing Companies Competitive Analysis
    3.1 World Human Microbiome Sequencing Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Human Microbiome Sequencing Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Human Microbiome Sequencing in 2022
        3.2.3 Global Concentration Ratios (CR8) for Human Microbiome Sequencing in 2022
    3.3 Human Microbiome Sequencing Company Evaluation Quadrant
    3.4 Human Microbiome Sequencing Market: Overall Company Footprint Analysis
        3.4.1 Human Microbiome Sequencing Market: Region Footprint
        3.4.2 Human Microbiome Sequencing Market: Company Product Type Footprint
        3.4.3 Human Microbiome Sequencing Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Human Microbiome Sequencing Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Human Microbiome Sequencing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Human Microbiome Sequencing Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Human Microbiome Sequencing Consumption Value Comparison
        4.2.1 United States VS China: Human Microbiome Sequencing Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Human Microbiome Sequencing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Human Microbiome Sequencing Companies and Market Share, 2018-2023
        4.3.1 United States Based Human Microbiome Sequencing Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Human Microbiome Sequencing Revenue, (2018-2023)
    4.4 China Based Companies Human Microbiome Sequencing Revenue and Market Share, 2018-2023
        4.4.1 China Based Human Microbiome Sequencing Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Human Microbiome Sequencing Revenue, (2018-2023)
    4.5 Rest of World Based Human Microbiome Sequencing Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Human Microbiome Sequencing Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Human Microbiome Sequencing Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Human Microbiome Sequencing Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Next-Generation Sequencing
        5.2.2 Traditional Sequencing Technologies
        5.2.3 Other
    5.3 Market Segment by Type
        5.3.1 World Human Microbiome Sequencing Market Size by Type (2018-2023)
        5.3.2 World Human Microbiome Sequencing Market Size by Type (2024-2029)
        5.3.3 World Human Microbiome Sequencing Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Human Microbiome Sequencing Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Genome Analysis
        6.2.2 Metabolome Analysis
        6.2.3 Transcriptome Analysis
        6.2.4 Other Omics Analysis
        6.2.5 Other Omics Analysis
    6.3 Market Segment by Application
        6.3.1 World Human Microbiome Sequencing Market Size by Application (2018-2023)
        6.3.2 World Human Microbiome Sequencing Market Size by Application (2024-2029)
        6.3.3 World Human Microbiome Sequencing Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Baseclear B.V.
        7.1.1 Baseclear B.V. Details
        7.1.2 Baseclear B.V. Major Business
        7.1.3 Baseclear B.V. Human Microbiome Sequencing Product and Services
        7.1.4 Baseclear B.V. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Baseclear B.V. Recent Developments/Updates
        7.1.6 Baseclear B.V. Competitive Strengths & Weaknesses
    7.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd
        7.2.1 Beijing Genomics Institute (BGI) Genomics Co., Ltd Details
        7.2.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd Major Business
        7.2.3 Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Product and Services
        7.2.4 Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Beijing Genomics Institute (BGI) Genomics Co., Ltd Recent Developments/Updates
        7.2.6 Beijing Genomics Institute (BGI) Genomics Co., Ltd Competitive Strengths & Weaknesses
    7.3 Charles River Laboratories International Inc.
        7.3.1 Charles River Laboratories International Inc. Details
        7.3.2 Charles River Laboratories International Inc. Major Business
        7.3.3 Charles River Laboratories International Inc. Human Microbiome Sequencing Product and Services
        7.3.4 Charles River Laboratories International Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Charles River Laboratories International Inc. Recent Developments/Updates
        7.3.6 Charles River Laboratories International Inc. Competitive Strengths & Weaknesses
    7.4 Clinical Microbiomics A/S
        7.4.1 Clinical Microbiomics A/S Details
        7.4.2 Clinical Microbiomics A/S Major Business
        7.4.3 Clinical Microbiomics A/S Human Microbiome Sequencing Product and Services
        7.4.4 Clinical Microbiomics A/S Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Clinical Microbiomics A/S Recent Developments/Updates
        7.4.6 Clinical Microbiomics A/S Competitive Strengths & Weaknesses
    7.5 Eurofins Scientific SE
        7.5.1 Eurofins Scientific SE Details
        7.5.2 Eurofins Scientific SE Major Business
        7.5.3 Eurofins Scientific SE Human Microbiome Sequencing Product and Services
        7.5.4 Eurofins Scientific SE Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Eurofins Scientific SE Recent Developments/Updates
        7.5.6 Eurofins Scientific SE Competitive Strengths & Weaknesses
    7.6 GENEWIZ, Inc.
        7.6.1 GENEWIZ, Inc. Details
        7.6.2 GENEWIZ, Inc. Major Business
        7.6.3 GENEWIZ, Inc. Human Microbiome Sequencing Product and Services
        7.6.4 GENEWIZ, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 GENEWIZ, Inc. Recent Developments/Updates
        7.6.6 GENEWIZ, Inc. Competitive Strengths & Weaknesses
    7.7 Illumina, Inc.
        7.7.1 Illumina, Inc. Details
        7.7.2 Illumina, Inc. Major Business
        7.7.3 Illumina, Inc. Human Microbiome Sequencing Product and Services
        7.7.4 Illumina, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Illumina, Inc. Recent Developments/Updates
        7.7.6 Illumina, Inc. Competitive Strengths & Weaknesses
    7.8 Novogene Corporation
        7.8.1 Novogene Corporation Details
        7.8.2 Novogene Corporation Major Business
        7.8.3 Novogene Corporation Human Microbiome Sequencing Product and Services
        7.8.4 Novogene Corporation Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Novogene Corporation Recent Developments/Updates
        7.8.6 Novogene Corporation Competitive Strengths & Weaknesses
    7.9 OraSure Technologies, Inc.
        7.9.1 OraSure Technologies, Inc. Details
        7.9.2 OraSure Technologies, Inc. Major Business
        7.9.3 OraSure Technologies, Inc. Human Microbiome Sequencing Product and Services
        7.9.4 OraSure Technologies, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 OraSure Technologies, Inc. Recent Developments/Updates
        7.9.6 OraSure Technologies, Inc. Competitive Strengths & Weaknesses
    7.10 Oxford Nanopore Technologies, Inc.
        7.10.1 Oxford Nanopore Technologies, Inc. Details
        7.10.2 Oxford Nanopore Technologies, Inc. Major Business
        7.10.3 Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Product and Services
        7.10.4 Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Oxford Nanopore Technologies, Inc. Recent Developments/Updates
        7.10.6 Oxford Nanopore Technologies, Inc. Competitive Strengths & Weaknesses
    7.11 Pacific Biosciences of California, Inc.
        7.11.1 Pacific Biosciences of California, Inc. Details
        7.11.2 Pacific Biosciences of California, Inc. Major Business
        7.11.3 Pacific Biosciences of California, Inc. Human Microbiome Sequencing Product and Services
        7.11.4 Pacific Biosciences of California, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Pacific Biosciences of California, Inc. Recent Developments/Updates
        7.11.6 Pacific Biosciences of California, Inc. Competitive Strengths & Weaknesses
    7.12 QIAGEN N.V.
        7.12.1 QIAGEN N.V. Details
        7.12.2 QIAGEN N.V. Major Business
        7.12.3 QIAGEN N.V. Human Microbiome Sequencing Product and Services
        7.12.4 QIAGEN N.V. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 QIAGEN N.V. Recent Developments/Updates
        7.12.6 QIAGEN N.V. Competitive Strengths & Weaknesses
    7.13 Second Genome, Inc.
        7.13.1 Second Genome, Inc. Details
        7.13.2 Second Genome, Inc. Major Business
        7.13.3 Second Genome, Inc. Human Microbiome Sequencing Product and Services
        7.13.4 Second Genome, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Second Genome, Inc. Recent Developments/Updates
        7.13.6 Second Genome, Inc. Competitive Strengths & Weaknesses
    7.14 Thermo Fisher Scientific Inc.
        7.14.1 Thermo Fisher Scientific Inc. Details
        7.14.2 Thermo Fisher Scientific Inc. Major Business
        7.14.3 Thermo Fisher Scientific Inc. Human Microbiome Sequencing Product and Services
        7.14.4 Thermo Fisher Scientific Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
        7.14.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
    7.15 Viome, Inc.
        7.15.1 Viome, Inc. Details
        7.15.2 Viome, Inc. Major Business
        7.15.3 Viome, Inc. Human Microbiome Sequencing Product and Services
        7.15.4 Viome, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Viome, Inc. Recent Developments/Updates
        7.15.6 Viome, Inc. Competitive Strengths & Weaknesses
    7.16 CosmosID
        7.16.1 CosmosID Details
        7.16.2 CosmosID Major Business
        7.16.3 CosmosID Human Microbiome Sequencing Product and Services
        7.16.4 CosmosID Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 CosmosID Recent Developments/Updates
        7.16.6 CosmosID Competitive Strengths & Weaknesses
    7.17 Leucine Rich Bio Pvt. Ltd.
        7.17.1 Leucine Rich Bio Pvt. Ltd. Details
        7.17.2 Leucine Rich Bio Pvt. Ltd. Major Business
        7.17.3 Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Product and Services
        7.17.4 Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.17.5 Leucine Rich Bio Pvt. Ltd. Recent Developments/Updates
        7.17.6 Leucine Rich Bio Pvt. Ltd. Competitive Strengths & Weaknesses
    7.18 Microba
        7.18.1 Microba Details
        7.18.2 Microba Major Business
        7.18.3 Microba Human Microbiome Sequencing Product and Services
        7.18.4 Microba Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.18.5 Microba Recent Developments/Updates
        7.18.6 Microba Competitive Strengths & Weaknesses
    7.19 Microbiome Insights Inc.
        7.19.1 Microbiome Insights Inc. Details
        7.19.2 Microbiome Insights Inc. Major Business
        7.19.3 Microbiome Insights Inc. Human Microbiome Sequencing Product and Services
        7.19.4 Microbiome Insights Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.19.5 Microbiome Insights Inc. Recent Developments/Updates
        7.19.6 Microbiome Insights Inc. Competitive Strengths & Weaknesses
    7.20 Molzym GmbH & Co. KG
        7.20.1 Molzym GmbH & Co. KG Details
        7.20.2 Molzym GmbH & Co. KG Major Business
        7.20.3 Molzym GmbH & Co. KG Human Microbiome Sequencing Product and Services
        7.20.4 Molzym GmbH & Co. KG Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
        7.20.5 Molzym GmbH & Co. KG Recent Developments/Updates
        7.20.6 Molzym GmbH & Co. KG Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Human Microbiome Sequencing Industry Chain
    8.2 Human Microbiome Sequencing Upstream Analysis
    8.3 Human Microbiome Sequencing Midstream Analysis
    8.4 Human Microbiome Sequencing Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer
btl

Table of Figures

List of Tables
    Table 1. World Human Microbiome Sequencing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Human Microbiome Sequencing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Human Microbiome Sequencing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Human Microbiome Sequencing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Human Microbiome Sequencing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Human Microbiome Sequencing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Human Microbiome Sequencing Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Human Microbiome Sequencing Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Human Microbiome Sequencing Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Human Microbiome Sequencing Players in 2022
    Table 12. World Human Microbiome Sequencing Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Human Microbiome Sequencing Company Evaluation Quadrant
    Table 14. Head Office of Key Human Microbiome Sequencing Player
    Table 15. Human Microbiome Sequencing Market: Company Product Type Footprint
    Table 16. Human Microbiome Sequencing Market: Company Product Application Footprint
    Table 17. Human Microbiome Sequencing Mergers & Acquisitions Activity
    Table 18. United States VS China Human Microbiome Sequencing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Human Microbiome Sequencing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Human Microbiome Sequencing Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Human Microbiome Sequencing Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Human Microbiome Sequencing Revenue Market Share (2018-2023)
    Table 23. China Based Human Microbiome Sequencing Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Human Microbiome Sequencing Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Human Microbiome Sequencing Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Human Microbiome Sequencing Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Human Microbiome Sequencing Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Human Microbiome Sequencing Revenue Market Share (2018-2023)
    Table 29. World Human Microbiome Sequencing Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Human Microbiome Sequencing Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Human Microbiome Sequencing Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Human Microbiome Sequencing Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Human Microbiome Sequencing Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Human Microbiome Sequencing Market Size by Application (2024-2029) & (USD Million)
    Table 35. Baseclear B.V. Basic Information, Area Served and Competitors
    Table 36. Baseclear B.V. Major Business
    Table 37. Baseclear B.V. Human Microbiome Sequencing Product and Services
    Table 38. Baseclear B.V. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Baseclear B.V. Recent Developments/Updates
    Table 40. Baseclear B.V. Competitive Strengths & Weaknesses
    Table 41. Beijing Genomics Institute (BGI) Genomics Co., Ltd Basic Information, Area Served and Competitors
    Table 42. Beijing Genomics Institute (BGI) Genomics Co., Ltd Major Business
    Table 43. Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Product and Services
    Table 44. Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Beijing Genomics Institute (BGI) Genomics Co., Ltd Recent Developments/Updates
    Table 46. Beijing Genomics Institute (BGI) Genomics Co., Ltd Competitive Strengths & Weaknesses
    Table 47. Charles River Laboratories International Inc. Basic Information, Area Served and Competitors
    Table 48. Charles River Laboratories International Inc. Major Business
    Table 49. Charles River Laboratories International Inc. Human Microbiome Sequencing Product and Services
    Table 50. Charles River Laboratories International Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Charles River Laboratories International Inc. Recent Developments/Updates
    Table 52. Charles River Laboratories International Inc. Competitive Strengths & Weaknesses
    Table 53. Clinical Microbiomics A/S Basic Information, Area Served and Competitors
    Table 54. Clinical Microbiomics A/S Major Business
    Table 55. Clinical Microbiomics A/S Human Microbiome Sequencing Product and Services
    Table 56. Clinical Microbiomics A/S Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Clinical Microbiomics A/S Recent Developments/Updates
    Table 58. Clinical Microbiomics A/S Competitive Strengths & Weaknesses
    Table 59. Eurofins Scientific SE Basic Information, Area Served and Competitors
    Table 60. Eurofins Scientific SE Major Business
    Table 61. Eurofins Scientific SE Human Microbiome Sequencing Product and Services
    Table 62. Eurofins Scientific SE Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Eurofins Scientific SE Recent Developments/Updates
    Table 64. Eurofins Scientific SE Competitive Strengths & Weaknesses
    Table 65. GENEWIZ, Inc. Basic Information, Area Served and Competitors
    Table 66. GENEWIZ, Inc. Major Business
    Table 67. GENEWIZ, Inc. Human Microbiome Sequencing Product and Services
    Table 68. GENEWIZ, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. GENEWIZ, Inc. Recent Developments/Updates
    Table 70. GENEWIZ, Inc. Competitive Strengths & Weaknesses
    Table 71. Illumina, Inc. Basic Information, Area Served and Competitors
    Table 72. Illumina, Inc. Major Business
    Table 73. Illumina, Inc. Human Microbiome Sequencing Product and Services
    Table 74. Illumina, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Illumina, Inc. Recent Developments/Updates
    Table 76. Illumina, Inc. Competitive Strengths & Weaknesses
    Table 77. Novogene Corporation Basic Information, Area Served and Competitors
    Table 78. Novogene Corporation Major Business
    Table 79. Novogene Corporation Human Microbiome Sequencing Product and Services
    Table 80. Novogene Corporation Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Novogene Corporation Recent Developments/Updates
    Table 82. Novogene Corporation Competitive Strengths & Weaknesses
    Table 83. OraSure Technologies, Inc. Basic Information, Area Served and Competitors
    Table 84. OraSure Technologies, Inc. Major Business
    Table 85. OraSure Technologies, Inc. Human Microbiome Sequencing Product and Services
    Table 86. OraSure Technologies, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. OraSure Technologies, Inc. Recent Developments/Updates
    Table 88. OraSure Technologies, Inc. Competitive Strengths & Weaknesses
    Table 89. Oxford Nanopore Technologies, Inc. Basic Information, Area Served and Competitors
    Table 90. Oxford Nanopore Technologies, Inc. Major Business
    Table 91. Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Product and Services
    Table 92. Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Oxford Nanopore Technologies, Inc. Recent Developments/Updates
    Table 94. Oxford Nanopore Technologies, Inc. Competitive Strengths & Weaknesses
    Table 95. Pacific Biosciences of California, Inc. Basic Information, Area Served and Competitors
    Table 96. Pacific Biosciences of California, Inc. Major Business
    Table 97. Pacific Biosciences of California, Inc. Human Microbiome Sequencing Product and Services
    Table 98. Pacific Biosciences of California, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Pacific Biosciences of California, Inc. Recent Developments/Updates
    Table 100. Pacific Biosciences of California, Inc. Competitive Strengths & Weaknesses
    Table 101. QIAGEN N.V. Basic Information, Area Served and Competitors
    Table 102. QIAGEN N.V. Major Business
    Table 103. QIAGEN N.V. Human Microbiome Sequencing Product and Services
    Table 104. QIAGEN N.V. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. QIAGEN N.V. Recent Developments/Updates
    Table 106. QIAGEN N.V. Competitive Strengths & Weaknesses
    Table 107. Second Genome, Inc. Basic Information, Area Served and Competitors
    Table 108. Second Genome, Inc. Major Business
    Table 109. Second Genome, Inc. Human Microbiome Sequencing Product and Services
    Table 110. Second Genome, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Second Genome, Inc. Recent Developments/Updates
    Table 112. Second Genome, Inc. Competitive Strengths & Weaknesses
    Table 113. Thermo Fisher Scientific Inc. Basic Information, Area Served and Competitors
    Table 114. Thermo Fisher Scientific Inc. Major Business
    Table 115. Thermo Fisher Scientific Inc. Human Microbiome Sequencing Product and Services
    Table 116. Thermo Fisher Scientific Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Thermo Fisher Scientific Inc. Recent Developments/Updates
    Table 118. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
    Table 119. Viome, Inc. Basic Information, Area Served and Competitors
    Table 120. Viome, Inc. Major Business
    Table 121. Viome, Inc. Human Microbiome Sequencing Product and Services
    Table 122. Viome, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Viome, Inc. Recent Developments/Updates
    Table 124. Viome, Inc. Competitive Strengths & Weaknesses
    Table 125. CosmosID Basic Information, Area Served and Competitors
    Table 126. CosmosID Major Business
    Table 127. CosmosID Human Microbiome Sequencing Product and Services
    Table 128. CosmosID Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 129. CosmosID Recent Developments/Updates
    Table 130. CosmosID Competitive Strengths & Weaknesses
    Table 131. Leucine Rich Bio Pvt. Ltd. Basic Information, Area Served and Competitors
    Table 132. Leucine Rich Bio Pvt. Ltd. Major Business
    Table 133. Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Product and Services
    Table 134. Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 135. Leucine Rich Bio Pvt. Ltd. Recent Developments/Updates
    Table 136. Leucine Rich Bio Pvt. Ltd. Competitive Strengths & Weaknesses
    Table 137. Microba Basic Information, Area Served and Competitors
    Table 138. Microba Major Business
    Table 139. Microba Human Microbiome Sequencing Product and Services
    Table 140. Microba Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 141. Microba Recent Developments/Updates
    Table 142. Microba Competitive Strengths & Weaknesses
    Table 143. Microbiome Insights Inc. Basic Information, Area Served and Competitors
    Table 144. Microbiome Insights Inc. Major Business
    Table 145. Microbiome Insights Inc. Human Microbiome Sequencing Product and Services
    Table 146. Microbiome Insights Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 147. Microbiome Insights Inc. Recent Developments/Updates
    Table 148. Molzym GmbH & Co. KG Basic Information, Area Served and Competitors
    Table 149. Molzym GmbH & Co. KG Major Business
    Table 150. Molzym GmbH & Co. KG Human Microbiome Sequencing Product and Services
    Table 151. Molzym GmbH & Co. KG Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 152. Global Key Players of Human Microbiome Sequencing Upstream (Raw Materials)
    Table 153. Human Microbiome Sequencing Typical Customers
List of Figure
    Figure 1. Human Microbiome Sequencing Picture
    Figure 2. World Human Microbiome Sequencing Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Human Microbiome Sequencing Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Human Microbiome Sequencing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Human Microbiome Sequencing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Human Microbiome Sequencing Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Human Microbiome Sequencing Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Human Microbiome Sequencing Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Human Microbiome Sequencing Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Human Microbiome Sequencing Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Human Microbiome Sequencing Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Human Microbiome Sequencing Revenue (2018-2029) & (USD Million)
    Figure 13. Human Microbiome Sequencing Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Human Microbiome Sequencing Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Human Microbiome Sequencing Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Human Microbiome Sequencing Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Human Microbiome Sequencing Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Human Microbiome Sequencing Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Human Microbiome Sequencing Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Human Microbiome Sequencing Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Human Microbiome Sequencing Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Human Microbiome Sequencing Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Human Microbiome Sequencing by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Human Microbiome Sequencing Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Human Microbiome Sequencing Markets in 2022
    Figure 27. United States VS China: Human Microbiome Sequencing Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Human Microbiome Sequencing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Human Microbiome Sequencing Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Human Microbiome Sequencing Market Size Market Share by Type in 2022
    Figure 31. Next-Generation Sequencing
    Figure 32. Traditional Sequencing Technologies
    Figure 33. Other
    Figure 34. World Human Microbiome Sequencing Market Size Market Share by Type (2018-2029)
    Figure 35. World Human Microbiome Sequencing Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Human Microbiome Sequencing Market Size Market Share by Application in 2022
    Figure 37. Genome Analysis
    Figure 38. Metabolome Analysis
    Figure 39. Transcriptome Analysis
    Figure 40. Other Omics Analysis
    Figure 41. Human Microbiome Sequencing Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Related Reports

btl

Product Tags

jiaGou

Add To Cart

gouMai

Buy Now